Join the HIV Infection group to help and get support from people like you.
HIV Infection News (Page 2)
Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS
Ozempic Eases Fatty Liver Disease in People Living With HIV
THURSDAY, March 7, 2024 – There's more good news around the diabetes and weight-loss drug Ozempic: It might help ease fatty liver disease in people living with HIV, new research shows. Six months of...
Drug-Emitting Vaginal Ring Safely Protects Pregnant Women From HIV
WEDNESDAY, March 6, 2024 – A vaginal ring that emits the antiviral dapivirine has passed safety trials and could shield vulnerable women against HIV infection during pregnancy, a new trial shows....
Mixed Digital Intervention Increases HIV Prevention Adherence in Young People
TUESDAY, March 5, 2024 – A synergistic effect is seen for multimodal strategies to improve uptake of and adherence to HIV prevention among young people at risk for acquisition, according to a study...
High Number of People on HIV-Preventing PrEP Stop Using It
TUESDAY, March 5, 2024 – Many people protected by drugs that prevent HIV infection quit using them, upping their vulnerability to the virus that causes AIDS, new research shows. The drug combo known...
U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy to Treat People with HIV with Suppressed Viral Loads, Pre-Existing Resistance
FOSTER CITY, Calif.--(BUSINESS WIRE) February 26, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved a new, expanded indication for...
People With Intellectual, Developmental Disabilities Experience HIV Disparities
FRIDAY, Feb. 23, 2024 – Disparities across the HIV care continuum exist for people with intellectual and developmental disabilities (IDDs), according to a study published in the February issue of...
Accelerated Epigenetic Aging Seen in Women With HIV
THURSDAY, Feb. 22, 2024 – Accelerated epigenetic aging is seen in women with HIV versus women without HIV, according to a study published online Feb. 15 in the Journal of Infectious Diseases. ...
Women With HIV Age Faster, Study Shows
FRIDAY, Feb. 16, 2024 – Women with HIV experience accelerated DNA aging, potentially leading to poorer physical function sooner in life than expected, a new study says. Markers of aging measured in...
Risk Factor Control May Modify Link Between HIV Status and Heart Disease
MONDAY, Jan. 22, 2024 – Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovascular disease (CVD), according to a study published online...
Increase in Out-of-Pocket Costs Could Increase Abandonment of HIV PrEP Meds
MONDAY, Jan. 8, 2024 – An increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to...
Court Ruling Could Bring Higher Patient Costs for PrEP, and More HIV Infections
TUESDAY, Jan. 9, 2024 – HIV pre-exposure prophylaxis (PrEP) is a lifeline for Americans, many of them gay men, who are at high risk of contracting the virus that causes AIDS. But a case that is...
Doxycycline Postexposure Prophylaxis Does Not Avert STIs in Women
THURSDAY, Dec. 21, 2023 – For Kenyan women receiving preexposure prophylaxis against HIV, the incidence of sexually transmitted infections (STIs) does not differ for those receiving doxycycline...
2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender Persons
MONDAY, Dec. 18, 2023 – From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published...
2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender Persons
MONDAY, Dec. 18, 2023 – From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published...
Theratechnologies Announces FDA Approval of Trogarzo 90-Second Intravenous (IV) Push Loading Dose
Updated label means new Trogarzo® patients no longer require initiation of treatment by 30-minute infusion Complete IV push method enables easier and more convenient administration of Trogarzo® for h...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Pre-Exposure Prophylaxis, Viral Infection
Related drug support groups
Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Genvoya, Triumeq